{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:27:00Z","timestamp":1770726420107,"version":"3.49.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1007\/s00277-019-03623-z","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T13:24:59Z","timestamp":1548768299000},"page":"1525-1527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical efficacy of bortezomib and lenalidomide in blastic plasmacytoid dendritic cell neoplasm"],"prefix":"10.1007","volume":"98","author":[{"given":"Chunli","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huawei","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"key":"3623_CR1","first-page":"58","volume":"89","author":"C Bueno","year":"2004","unstructured":"Bueno C, Almeida J, Lucio P, Marco J, Garcia R, de Pablos JM, Parreira A, Ramos F, Ruiz-Cabello F, Suarez-Vilela D, San Miguel JF, Orfao A (2004) Incidence and characteristics of CD4(+)\/HLA DRhi dendritic cell malignancies. Haematologica 89:58\u201369","journal-title":"Haematologica"},{"key":"3623_CR2","doi-asserted-by":"publisher","first-page":"19204","DOI":"10.18632\/oncotarget.4146","volume":"6","author":"L Martin-Martin","year":"2015","unstructured":"Martin-Martin L, Lopez A, Vidriales B et al (2015) Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile. Oncotarget 6:19204\u201319216","journal-title":"Oncotarget"},{"key":"3623_CR3","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1309\/GJWNPD8HU5MAJ837","volume":"123","author":"T Petrella","year":"2005","unstructured":"Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, Meijer CJLM, Courville P, Joly P, Grange F, de Muret A, Machet L, Dompmartin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D\u2019Incan M, Wechsler J, Teitell MA (2005) Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms). Am J Clin Pathol 123:662\u2013675","journal-title":"Am J Clin Pathol"},{"key":"3623_CR4","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/leu.2014.64","volume":"28","author":"MR Sapienza","year":"2014","unstructured":"Sapienza MR, Fuligni F, Agostinelli C et al (2014) Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition. Leukemia 28:1606\u20131616","journal-title":"Leukemia"},{"key":"3623_CR5","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1182\/blood-2006-04-018143","volume":"109","author":"RVDK Remco Dijkman","year":"2007","unstructured":"Remco Dijkman RVDK (2007) Gene-expression profiling and array-based CGH classify CD4+CD56+hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities. Blood 109:1720\u20131727","journal-title":"Blood"},{"key":"3623_CR6","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.3324\/haematol.2017.169326","volume":"102","author":"L Philippe","year":"2017","unstructured":"Philippe L, Ceroi A, B\u00f4le-Richard E, Jenvrin A, Biichle S, Perrin S, Limat S, Bonnefoy F, Deconinck E, Saas P, Garnache-Ottou F, Angelot-Delettre F (2017) Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm. Haematologica 102:1861\u20131868","journal-title":"Haematologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-019-03623-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03623-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03623-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:34:31Z","timestamp":1659058471000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-019-03623-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6,1]]}},"alternative-id":["3623"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03623-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]},"assertion":[{"value":"4 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from the participating patient of the case description.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}